Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06655441
PHASE4

The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function

Sponsor: Southern California College of Optometry at Marshall B. Ketchum University

View on ClinicalTrials.gov

Summary

The purpose of this research study is to evaluate the effects of trehalose, an ingredient found in commercially available artificial tears, on the corneal barrier function. The investigators will assess corneal dryness and measure the relative corneal epithelial "barrier" function (the degree to which the cornea can prevent penetration of sodium fluorescein dye into the eye) after using eye drops that contain 3% trehalose for one month.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-09-01

Completion Date

2025-12

Last Updated

2025-06-15

Healthy Volunteers

No

Interventions

DRUG

3% trehalose

ophthalmic solution with 3% trehalose in sterile saline in multi dose preservative free bottles

Locations (1)

Marshall B. Ketchum University

Fullerton, California, United States